Bioinformatics Analysis of Differentially Expressed Genes and Protein-Protein Interaction Networks Associated with Functional Pathways in Ulcerative Colitis.
Journal
Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063
Informations de publication
Date de publication:
19 Jan 2021
19 Jan 2021
Historique:
entrez:
19
1
2021
pubmed:
20
1
2021
medline:
22
5
2021
Statut:
epublish
Résumé
BACKGROUND This bioinformatics study aimed to identify differentially expressed genes (DEGs) and protein-protein interaction (PPI) networks associated with functional pathways in ulcerative colitis based on 3 Gene Expression Omnibus (GEO) datasets. MATERIAL AND METHODS The GSE87466, GSE75214, and GSE48958 MINiML formatted family files were downloaded from the GEO database. DEGs were identified from the 3 datasets, and volcano maps and heat maps were drawn after R language standardization and analysis, respectively. Venn diagram software was used to identify common DEGs. PPI analysis of common DEGs was performed using the Search Tool for the Retrieval of Interacting Genes. Gene modules and hub genes were visualized in the PPI network using Cytoscape. Enrichment analysis was performed for all common DEGs, module genes, and hub genes. RESULTS A total of 90 DEGs were selected, which included 3 functional modules and 1 hub gene module. CXCL8 module genes were mainly enriched in cytokine-mediated signaling pathways and interleukin (IL)-10 signaling. CCL20 module genes were mainly enriched in the IL-17 signaling pathway and cellular response to IL-1. Hub gene modules mainly involved IL-10, IL-4, and IL-13 signaling pathways. CXCL8, CXCL1, and IL-1ß were the top 3 hub genes and were mainly involved in IL-10 signaling. CONCLUSIONS Bioinformatics analysis using 3 GEO datasets identified CXCL8, CXCL1, and IL-1ß, which are involved in IL-10 signaling, as the top 3 hub genes in ulcerative colitis. The findings from this study remain to be validated, but they may contribute to the further understanding of the pathogenesis of ulcerative colitis.
Identifiants
pubmed: 33462173
pii: 927917
doi: 10.12659/MSM.927917
pmc: PMC7824989
doi:
Substances chimiques
CXCL1 protein, human
0
CXCL8 protein, human
0
Chemokine CXCL1
0
Interleukin-1beta
0
Interleukin-8
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e927917Références
Lancet. 2017 Apr 29;389(10080):1756-1770
pubmed: 27914657
Dig Dis Sci. 2006 Jan;51(1):173-7
pubmed: 16416232
Gastroenterology. 2020 Jun;158(8):2195-2207.e6
pubmed: 32084424
Cell Death Dis. 2020 Feb 3;11(2):86
pubmed: 32015337
Cancer Immunol Res. 2020 Feb;8(2):167-178
pubmed: 31831633
Inflamm Bowel Dis. 2017 Jun;23(6):923-931
pubmed: 28486255
J Immunol. 1993 Dec 1;151(11):6370-81
pubmed: 7902377
Colorectal Dis. 2018 Jan;20(1):44-52
pubmed: 28667683
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Cell Mol Gastroenterol Hepatol. 2018 Mar 09;6(1):65-78
pubmed: 29928672
J Ovarian Res. 2019 Apr 22;12(1):35
pubmed: 31010415
Mediators Inflamm. 2017;2017:4810258
pubmed: 28420941
Exp Ther Med. 2019 Jul;18(1):278-288
pubmed: 31258663
Int J Mol Sci. 2018 Oct 20;19(10):
pubmed: 30347808
Cells. 2020 Mar 11;9(3):
pubmed: 32168749
Cell Death Dis. 2020 Jan 27;11(1):68
pubmed: 31988296
J Med Food. 2020 Apr;23(4):440-452
pubmed: 32186945
Int Immunol. 1994 Apr;6(4):661-4
pubmed: 8018602
J Dig Dis. 2008 Aug;9(3):144-8
pubmed: 18956592
Cancer Immunol Res. 2020 May;8(5):660-671
pubmed: 32161110
Curr Res Transl Med. 2019 May;67(2):41-50
pubmed: 30685379
J Crohns Colitis. 2020 Jul 9;14(6):831-840
pubmed: 31679013
J Immunol. 1999 Aug 1;163(3):1537-44
pubmed: 10415057
Gastroenterology. 2013 Jul;145(1):158-165.e2
pubmed: 23583432
Nature. 2018 Nov;563(7730):S33
pubmed: 30405234
Tumour Biol. 2017 Jun;39(6):1010428317712445
pubmed: 28639898
BMC Cardiovasc Disord. 2016 Nov 11;16(1):218
pubmed: 27835972
Gastroenterol Res Pract. 2018 Jul 29;2018:7265812
pubmed: 30147719
World J Gastroenterol. 2018 Feb 7;24(5):583-592
pubmed: 29434447
Mol Med Rep. 2017 Nov;16(5):7479-7489
pubmed: 28944823
Front Oncol. 2020 Jan 10;9:1515
pubmed: 31998654
Onco Targets Ther. 2017 Nov 21;10:5561-5573
pubmed: 29200871
Cell Death Dis. 2017 Aug 10;8(8):e2993
pubmed: 28796256
Front Immunol. 2020 Jan 28;10:3104
pubmed: 32063899
Tumour Biol. 2016 Jun;37(6):7441-52
pubmed: 26678887
Biosci Rep. 2019 May 31;39(5):
pubmed: 31088900